EMEA-001631-PIP01-14-M04
Key facts
Invented name |
Prevymis
|
Active substance |
Letermovir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0362/2019
|
PIP number |
EMEA-001631-PIP01-14-M04
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Prevention of cytomegalovirus infection
|
Route(s) of administration |
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|